157 related articles for article (PubMed ID: 3895033)
41. [Neuroendocrine aspects of Parkinson's disease. Therapeutic/effect of a prolactin inhibitor].
Agnoli A; Casacchia M; Carolei A; Meco G; Zamponi A; Ruggieri S
Minerva Med; 1976 Nov; 67(53):. PubMed ID: 1036612
[TBL] [Abstract][Full Text] [Related]
42. Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy.
Factor SA; Sanchez-Ramos JR; Weiner WJ
J Neurol Neurosurg Psychiatry; 1988 Apr; 51(4):529-33. PubMed ID: 3288717
[TBL] [Abstract][Full Text] [Related]
43. Mesulergine and pergolide in previously untreated Parkinson's disease.
Wright A; Lees AJ; Stern GM
J Neurol Neurosurg Psychiatry; 1987 Apr; 50(4):482-4. PubMed ID: 3585362
[TBL] [Abstract][Full Text] [Related]
44. Clinical studies with bromocriptine in idiopathic parkinsonism.
Teychenne PF; Kartzinel R; Perlow M; Pfeiffer R; Calne DB
Trans Am Neurol Assoc; 1976; 101():302-4. PubMed ID: 1037483
[No Abstract] [Full Text] [Related]
45. Bromocriptine and Parkinson's disease: a 16-hour clinical evaluation.
Grøn U; Friis ML; Pakkenberg H
Acta Neurol Scand; 1980 Feb; 61(2):131-6. PubMed ID: 6994422
[TBL] [Abstract][Full Text] [Related]
46. Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.
Pezzoli G; Martignoni E; Pacchetti C; Angeleri VA; Lamberti P; Muratorio A; Bonuccelli U; De Mari M; Foschi N; Cossutta E
Mov Disord; 1994 Jul; 9(4):431-6. PubMed ID: 7969210
[TBL] [Abstract][Full Text] [Related]
47. An evaluation of bromocriptine in the treatment of Parkinson's disease.
Mackenzie RA; Lance JW
Clin Exp Neurol; 1978; 15():228-36. PubMed ID: 386307
[TBL] [Abstract][Full Text] [Related]
48. A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.
Libman I; Gawel MJ; Riopelle RJ; Bouchard S
Can J Neurol Sci; 1987 Nov; 14(4):576-80. PubMed ID: 3319120
[TBL] [Abstract][Full Text] [Related]
49. [Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study].
Fischer PA; Przuntek H; Majer M; Welzel D
Dtsch Med Wochenschr; 1984 Aug; 109(34):1279-83. PubMed ID: 6381019
[TBL] [Abstract][Full Text] [Related]
50. Assessment of hypokinesia in Parkinsonism.
Teräväinen H; Calne DB
J Neural Transm; 1981; 51(1-2):149-59. PubMed ID: 7021768
[TBL] [Abstract][Full Text] [Related]
51. Letter: Bromocriptine in parkinsonism.
Lees AJ; Shaw KM; Stern GM
Lancet; 1975 Oct; 2(7937):709-10. PubMed ID: 52084
[No Abstract] [Full Text] [Related]
52. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Clarke CE; Deane KH
Cochrane Database Syst Rev; 2000; 2001(3):CD001517. PubMed ID: 10908504
[TBL] [Abstract][Full Text] [Related]
53. A multi-center, double-blind study on slow-release bromocriptine in the treatment of Parkinson's disease.
Mannen T; Mizuno Y; Iwata M; Goto I; Kanazawa I; Kowa H; Nishitani H; Ogawa N; Takahashi A; Tashiro K
Neurology; 1991 Oct; 41(10):1598-602. PubMed ID: 1922801
[TBL] [Abstract][Full Text] [Related]
54. Low-dose bromocriptine therapy in severe Parkinson's disease.
Devathasan G; Chong PN; Puvanendran K; Lun KC; Wong PK
Clin Neuropharmacol; 1984; 7(3):231-7. PubMed ID: 6386152
[TBL] [Abstract][Full Text] [Related]
55. [Efficacy and safety of ropinirole in the treatment of Parkinson's disease: a multi-center, randomized, double-blind and bromocriptine-controlled trial].
Li SH; Chen HB; Wang ZF; Tang RH; Zhang XY; Yang JS; Zhao WQ; Sun XR; Ma J
Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(25):1952-7. PubMed ID: 24169242
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of pergolide and mesulergine.
Lieberman AN; Gopinathan G; Neophytides A
Eur Neurol; 1986; 25(2):86-90. PubMed ID: 3948891
[TBL] [Abstract][Full Text] [Related]
57. Bromocriptine in Parkinson disease.
Lieberman AN; Goldstein M
Pharmacol Rev; 1985 Jun; 37(2):217-27. PubMed ID: 3901046
[TBL] [Abstract][Full Text] [Related]
58. Bromocriptine versus levodopa in early Parkinson's disease.
Ramaker C; van Hilten JJ
Cochrane Database Syst Rev; 2000; (3):CD002258. PubMed ID: 10908538
[TBL] [Abstract][Full Text] [Related]
59. DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S53-67. PubMed ID: 12211141
[No Abstract] [Full Text] [Related]
60. Bromocriptine and lisuride in Parkinson disease.
Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
